Education
About Us
Working with TipRanks
Follow Us
Sonendo (SONX)
OTHER OTC:SONX
SONX Stock Chart & Stats
$0.41
$0.19(9.22%)
At close: 4:00 PM EST
$0.41
$0.19(9.22%)
Day’s Range― - ―
52-Week Range$0.01 - $10.41
Previous CloseN/A
Volume1.59K
Average Volume (3M)389.00
Market Cap
$175.23K
Enterprise Value$6.93M
Total Cash (Recent Filing)$11.63M
Total Debt (Recent Filing)$17.85M
Price to Earnings (P/E)―
Beta0.79
Next Earnings
Nov 05, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding427,401
10 Day Avg. Volume222
30 Day Avg. Volume389
Financial Highlights & Ratios
PEG Ratio0.33
Price to Book (P/B)16.56
Price to Sales (P/S)2.71
P/FCF Ratio-3.46
Enterprise Value/Market Cap39.53
Enterprise Value/Revenue0.22
Enterprise Value/Gross Profit0.58
Enterprise Value/Ebitda-0.25
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Sonendo News
SONX FAQ
What was Sonendo’s price range in the past 12 months?
Sonendo lowest stock price was $0.01 and its highest was $10.41 in the past 12 months.
What is Sonendo’s market cap?
Sonendo’s market cap is $175.23K.
When is Sonendo’s upcoming earnings report date?
Sonendo’s upcoming earnings report date is Nov 05, 2025 which is in 10 days.
How were Sonendo’s earnings last quarter?
Currently, no data Available
Is Sonendo overvalued?
According to Wall Street analysts Sonendo’s price is currently Overvalued.
Does Sonendo pay dividends?
Sonendo does not currently pay dividends.
What is Sonendo’s EPS estimate?
Sonendo’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sonendo have?
Sonendo has 427,401 shares outstanding.
What happened to Sonendo’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Sonendo?
Currently, no hedge funds are holding shares in SONX
Company Description
Sonendo
Sonendo, Inc. (SONX) is a medical technology company specializing in the development of advanced dental technologies, specifically focused on endodontics, or root canal treatments. The company's flagship product, the GentleWave System, utilizes a proprietary ultrasound technology to improve the efficiency and effectiveness of root canal procedures. By enhancing the cleaning and disinfection of the root canal system, Sonendo aims to provide better outcomes for patients while transforming dental practices with innovative solutions.
Technical Analysis
Ownership Overview
― Insiders
1.08% Mutual Funds
― Other Institutional Investors
98.92% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---